Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2014 16:01 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics Reports First Quarter 2014 Financial Results

SHELTON, Conn., May 12, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
May 05, 2014 16:01 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics to Announce First Quarter 2014 Financial Results on May 12, 2014

SHELTON, Conn., May 5, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate...
April 02, 2014 16:01 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics to Webcast Presentation at 13th Annual Needham Healthcare Conference

SHELTON, Conn., April 2, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
March 27, 2014 16:01 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results

SHELTON, Conn., March 27, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
March 20, 2014 16:01 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics to Announce Fourth Quarter and Full Year 2013 Financial Results on March 27, 2014

SHELTON, Conn., March 20, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
February 05, 2014 16:01 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Over-Allotment Option

SHELTON, Conn., Feb. 5, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
January 31, 2014 07:00 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics Announces Pricing of Initial Public Offering

SHELTON, Conn., Jan. 31, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain by...